NON-SMALL CELL LUNG CARCINOMA
Clinical trials for NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer pill trial halted early
Disease control TerminatedThis early-stage study tested an experimental pill called PRT7732 in people with advanced solid tumors that have a specific genetic mutation (SMARCA4). The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study was terminated early, an…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:15 UTC
-
New cancer pill shows promise in early trial, but study halted
Disease control TerminatedThis early-phase study tested an experimental oral drug called IK-595 in 75 adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have specific RAS or RAF gene mutations and no standard treatment options left. The goal was to check the drug's safety…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Experimental combo therapy trial halted early
Disease control TerminatedThis early-stage trial tested a new drug (TNO155) combined with either spartalizumab or ribociclib in adults with advanced solid tumors like lung, head and neck, and colorectal cancers. The main goal was to check safety and find the right dose. The study was terminated, so result…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:40 UTC